You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small Molecule Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Breast Cancer Trial in Guangzhou (Take probiotics)

Recruiting
  • Breast Cancer
  • Take probiotics
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 6, 2023

Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

Active, not recruiting
  • Ovarian Neoplasms
  • +2 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Brussels, Belgium
  • +4 more
Dec 19, 2022

AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

Terminated
Has Results
  • AML Including AML de Novo and AML Secondary to MDS
  • DLBCL
  • Birabresib Dose 20 mg
  • (no location specified)
Aug 23, 2022

Primary Sclerosing Cholangitis Trial in Phoenix, Tempe, Rochester (Vidofludimus calcium)

Completed
Has Results
  • Primary Sclerosing Cholangitis
  • Vidofludimus calcium
  • Phoenix, Arizona
  • +2 more
Oct 11, 2022

B-Cell Lymphoma Trial in United States (CPI-1205)

Completed
  • B-Cell Lymphoma
  • Lafayette, Indiana
  • +5 more
May 16, 2022

Cancer of Pancreas, Cancer of the Pancreas, Tumors, Pancreatic Trial in Boston, New York (Talabostat Mesylate)

Withdrawn
  • Cancer of Pancreas
  • +4 more
  • Talabostat Mesylate
  • Boston, Massachusetts
  • +1 more
Feb 8, 2022

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • Stanford, California
    Stanford University
Mar 31, 2022

Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)

Active, not recruiting
  • Carcinosarcoma, Ovarian
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Sep 27, 2021

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Glioblastoma Multiforme Trial (Birabresib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • (no location specified)
Jan 7, 2021

NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)

Terminated
Has Results
  • NUT Midline Carcinoma (NMC)
  • +3 more
  • (no location specified)
Jan 7, 2021

Advanced/Metastatic Solid Tumor Trial in United States (KZR-261)

Recruiting
  • Advanced/Metastatic Solid Tumor
  • Los Angeles, California
  • +6 more
Aug 10, 2022

Nutrition, Healthy Trial in Re?ovot (nutritional)

Recruiting
  • Nutrition, Healthy
  • nutritional
  • Reẖovot, Israel
    Weizmann Institute of Science
Jul 16, 2023

Exploratory Drug Interaction Study Between SMIs and DOACs

Recruiting
  • Solid Tumor
  • Cancer, Lung
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Feb 7, 2023

    Neurodegenerative Diseases Trial (SMARTO ONE, )

    Not yet recruiting
    • Neurodegenerative Diseases
    • SMARTO ONE
    • placebo
    • (no location specified)
    Jul 14, 2023

    Neurodegenerative Diseases Trial (SMARTO ONE)

    Not yet recruiting
    • Neurodegenerative Diseases
    • SMARTO ONE
    • (no location specified)
    Jul 14, 2023

    Retinitis Pigmentosa Trial (KIO-301)

    Recruiting
    • Retinitis Pigmentosa
    • Adelaide, South Australia, Australia
      Royal Adeliade Hospital
    Dec 22, 2022

    Small Molecule LCDM and GV Oocyte

    Not yet recruiting
    • Assisted Reproduction
    • Small molecule LCDM
    • (no location specified)
    Apr 26, 2022

    Colorectal Cancer, Pancreatic Cancer, Metastatic Cancer Trial in Lyon, Toulouse (Pexidartinib, Durvalumab)

    Completed
    • Colorectal Cancer
    • +3 more
    • Lyon, France
    • +1 more
    Sep 2, 2021

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

    Completed
    • Clear Cell Renal Cell Carcinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Feb 6, 2023

    Biologics or Small Molecule Therapies in Inflammatory Bowel

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
      • New York, New York
      • +1 more
      Jan 9, 2023

      Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

      Recruiting
      • Non Small Cell Lung Cancer
      • +16 more
      • Goodyear, Arizona
      • +10 more
      Jan 24, 2023

      Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

      Recruiting
      • Advanced Solid Tumor
      • Refractory Tumor
      • Radiotherapy
      • +4 more
      • Suzhou, China
        The Second Affiliated Hospital of SchoowUniversity
      Sep 14, 2023

      Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • TACE（transcatheter arterial chemoembolization）
      • +2 more
      • (no location specified)
      Jun 5, 2023